Royalty Pharma plcRPRXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank56
5Y CAGR+50.2%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
+50.2%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
7.6x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.41% |
| Q3 2025 | 5.59% |
| Q2 2025 | 4.06% |
| Q1 2025 | -3.37% |
| Q4 2024 | 1.00% |
| Q3 2024 | 2.18% |
| Q2 2024 | 9.46% |
| Q1 2024 | -1.53% |
| Q4 2023 | 3.32% |
| Q3 2023 | -7.39% |
| Q2 2023 | 0.28% |
| Q1 2023 | 1.55% |
| Q4 2022 | -4.86% |
| Q3 2022 | -0.38% |
| Q2 2022 | 2.08% |
| Q1 2022 | -0.78% |
| Q4 2021 | -1.22% |
| Q3 2021 | 7.37% |
| Q2 2021 | 3.78% |
| Q1 2021 | -0.66% |
| Q4 2020 | 0.19% |
| Q3 2020 | 1.95% |
| Q2 2020 | 17.30% |
| Q1 2020 | 7.40% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |